Skip to content

Caregiver Burden in Huntington's Disease

Assessment Study on Family Burden in Overall Care of Patient With Huntington Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02876445
Acronym
PHRI-HD
Enrollment
179
Registered
2016-08-23
Start date
2011-03-31
Completion date
2016-03-31
Last updated
2016-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver of Huntington's Disease Patient

Keywords

Huntington's disease, Caregiver, ZARIT burden scale

Brief summary

Huntington's disease (HD) is a rare inherited neurodegenerative disorder, progressing between 15 and 20 years and affecting one person out of 10.000. In France, it concerns some 6.000 patients symptomatic and 12 000 asymptomatic carriers. Few extensive researches have been conducted on the progression of the disease, which is defined in the literature in 5 stages in a functional approach. Therapeutically, no cure for HD is currently validated but only symptomatic treatments. There's various treatment options: medicated, humans (physiotherapy, speech therapist, occupational therapist, ..). Although these treatment options do not prevent the progression of the disease, their combination associated with a stimulating environment may slow the decline of physical, intellectual and psychic abilities of patients. In social terms, patients with HD require sustained support, especially in cases of family isolation. The behavioural, gaiting and eating disorder as well as the communications difficulties make it difficult support daily for the entourage. The caregivers are sometimes dealing with untenable situations. Home care services, which are crucial to alleviating dependency, relieve family caregivers but are for the most severe patient. Moreover, the justified placement decision in an institution generates a feeling of guilt for the family. The caregiver is the person who brings non-professional assistance , partly or wholly , to a dependent member of his entourage , for the activities of daily living. This regular care may be provided permanently or not. It can take many forms, such as , care , nursing , support to education and social life , administrative procedures , psychological support . Caregivers have their lives profoundly reshaped. They are often forced to give up some of their habits , give up their future plans , change their relationships. The commitment of caregivers with patients with Huntington's disease actually sounds on their mental and physical health, as well as their social and professional life Very few studies have been conducted to measure the difficulties and implications of these caregivers.

Interventions

OTHERZARIT Burden Interview

ZARIT Burden Interview completed Day 0 and 1 year

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 * Primary caregiver of patient with Huntington's disease * Non- institutionalized Patient * stage 1-4 (no institutionalization within 2 years) * written consent

Exclusion criteria

\- Not agreement

Design outcomes

Primary

MeasureTime frame
Evaluation with ZARIT's scale of the burden level of the management of a patient with Huntington's disease by his caregiver1 year

Secondary

MeasureTime frame
Measuring social impact of the disease using the under score of ZARIT's scale for the patient and the caregiver1 year
Measuring professional impact of of the disease using the under score of ZARIT's scale for the patient and the caregiver1 year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026